CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

Over 3 million procedures were performed globally on Intuitive daVinci systems last year, accounting for an 18% increase.

Fourth quarter 2025 worldwide procedures (da Vinci and Ion combined) grew approximately 18% compared with the fourth quarter of 2024. Da Vinci procedures grew approximately 17% and Ion procedures grew ...

Intuitive Surgical, with its Da Vinci robots, enjoys a great competitive position in minimally invasive surgery, driven by $6 billion in R&D and first-mover advantage. The business model, with 84% ...

Both companies are high-quality MedTech leaders, but their upside profiles diverge. Stryker’s diversification, consistent ...

Intuitive Surgical is the market leader in robotic surgery systems, and has ample growth prospects. Medtronic has a diversified business, some growth opportunities, and a fantastic dividend record.

We recently published a list of the 10 Best Medical Device Stocks To Buy According to Hedge Funds. In this article, we are going to take a look at where Intuitive Surgical, Inc. (NASDAQ:ISRG) stands ...